Vector Science and Therapeutics Corp. (TSXV: PAIN) ("Vector" or the "Company") today introduced its investigational ...

Spread the loveImagine winding back the clock, not on a dusty antique, but on your very own cells. It sounds like something ...

Charles River Laboratories International (CRL) drew fresh investor attention after announcing a collaboration with Magellan ...

A review identifies crosslinking as a multidimensional design variable influencing mechanics, transport, degradation and cell ...

Nasdaq closes reporting deficiency following filing of second-quarter 2026 Form 10-QFLORHAM PARK, N.J., Oct. 22, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: CELU) (“Celularity”), a longevity-focused ...

For example, scientists worldwide are racing to use stem cells to replace—or even rejuvenate—cells damaged by macular ...

A second Brazil event in a single year - a frequency ISSCA has not previously applied - underscores Brazil's priority ...

MS Bio traded up 74% from its 7,800 won IPO price on its KOSDAQ debut but fell about 15% from its 16,000 won opening price as profit-taking emerged.

SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO ...

Researchers have outlined a plan for slowing aging by targeting one of the body's most important cellular communication ...

Tissue, a Belgian medtech company developing solutions for regenerative medicine, announces a €7 million Series A financing ...

On October 20, 2026, Arthur D. Little Japan (ADL) published a white paper outlining policy recommendations for regenerative ...